ARTICLE | Clinical News
Pradax dabigatran etexilate regulatory update
November 1, 2010 7:00 AM UTC
Health Canada approved Pradax dabigatran etexilate from Boehringer to prevent stroke and systemic embolism in atrial fibrillation (AF) patients. The direct oral thrombin inhibitor is already approved ...